Skip to Content
MilliporeSigma
  • Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge.

Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge.

Circulation research (2008-06-04)
Sailay Siddiqi, Natalie Gude, Toru Hosoda, John Muraski, Marta Rubio, Gregory Emmanuel, Jenna Fransioli, Serena Vitale, Carola Parolin, Domenico D'Amario, Erik Schaefer, Jan Kajstura, Annarosa Leri, Piero Anversa, Mark A Sussman
ABSTRACT

Stem cell-specific proteins and regulatory pathways that determine self-renewal and differentiation have become of fundamental importance in understanding regenerative and reparative processes in the myocardium. One such regulatory protein, named nucleostemin, has been studied in the context of stem cells and several cancer cell lines, where expression is associated with proliferation and maintenance of a primitive cellular phenotype. We find nucleostemin is present in young myocardium and is also induced following cardiomyopathic injury. Nucleostemin expression in cardiomyocytes is induced by fibroblast growth factor-2 and accumulates in response to Pim-1 kinase activity. Cardiac stem cells also express nucleostemin that is diminished in response to commitment to a differentiated phenotype. Overexpression of nucleostemin in cultured cardiac stem cells increases proliferation while preserving telomere length, providing a mechanistic basis for potential actions of nucleostemin in promotion of cell survival and proliferation as seen in other cell types.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Tropomyosin (Sarcomeric) antibody, Mouse monoclonal, clone CH1, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Glyceraldehyde-3-Phosphate Dehydrogenase Antibody, clone 6C5, clone 6C5, Chemicon®, from mouse